mail
versión imprimible
 
 

13th Process Development for Highly Potent Drugs Summit (HPAPI)

Evvnt Promotion / evvnt
-
25.06.2024 - 27.06.2024  Delta Hotel Philadelphia Airport, 500 Stevens Drive, 19113 Philadelphia, Pennsylvania, USA
Time: 1:30 PM - 3:45 PM
 
Temas de la conferencia
From Process Safety to Rapid Scale-Up to Tech Transfer: Integrating Process Development, Industrial Hygiene and Equipment Selection to Achieve GMP Manufacturing of Novel High Potent Drug Compounds 2023 has been a pivotal year for novel high potent compounds securing early success and approvals – from Henlius’s ADC to Gilead’s Trodelvy to BMS’s Augtyro, cementing the growth of highly potent drugs market to reach USD$40.7bn by 2023.
Organizador profesional (PCO)
Hanson Wade Group
Observaciones
URL:
Brochure: https://go.evvnt.com/2316046-3?pid=4832

Speakers: Antonio Hernandez-Cardoso, Senior Principal Scientist, US Pharmacopiea, and more
 

Información e inscripción:

https://go.evvnt.com/2316046-2?pid=4832
Ms. Gracia Carr
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 2599.00 - USD 5197.00
Los participantes esperaban
1000 - 1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Alumni Club Medizinische Universität WienAMREF - African Medical and Research FoundationEuropean Public Health Association (EUPHA)Österreichisches Rotes KreuzAGEM - Arbeitsgemeinschaft Ethnologie und MedizinEuropean Health Forum GasteinHelix - Forschung & Beratung WienOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation